23andMe

Wall Street saw a strong rally on Monday as investors grew optimistic about easing trade tensions and solid economic data. The S&P 500 and Nasdaq posted their best gains in months, with the S&P 500 climbing 1.76% to 5,767.57 and the Nasdaq rising 2.3% to 18,188.59. The Dow Jones Industrial...

In a recent announcement, 23andMe Holding Co. (NASDAQ:ME) has disclosed that the U.S. Food and Drug Administration (FDA) has given the green light to its investigational new drug application for 23ME-01473 (‘1473), a natural killer (NK) cell activator designed to combat cancer. What Happened...

Editor’s note: The headline of this story has been updated to reflect that 23andMe ancestry data was hacked — not DNA data. In a significant security breach, genetic testing company 23andMe Holding Co. (NASDAQ:ME), confirmed that hackers have accessed around 14,000 customer accounts and an...

Personalized DNA testing company 23andMe is going public with a SPAC deal announced Thursday. The SPAC Deal: 23andMe is going public with VG Acquisition Corp (NYSE: VGAC), a SPAC from Virgin Group. The deal values 23andMe at $3.5 billion. A $250-million PIPE includes $25-million investments from...

The year has been good for pharma and biotech companies, with earnings, drug approvals and M&A fueling strong buying in the space. Another multibillion-dollar deal was announced Monday. What Happened Large-cap biotech GlaxoSmithKline plc (NYSE: GSK) and TESARO Inc (NASDAQ: TSRO) announced a...

Take-home DNA kits have quickly become the newest trend in genetic testing. Founded in 2006, 23andMe has helped millions of customers access and understand their personal DNA information. Then in 2015, the company launched 23andMe Therapeutics to create treatments and cures based on genetic...

A breakout year for IPO has yet to materialize after the stellar showing in both 2013 and 2014. The performance in 2017 can at best be qualified as lukewarm — despite the record run of the equity markets. IPOs could become easier, gaccording to a report in the Wall Street Journal Thursday...